← Back to Search

Vitamin

Riboflavin for Muscle Pain

Phase < 1
Recruiting
Led By Steven Moore, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights

Study Summary

This trial will study if vitamin B2 can reduce muscle soreness after an ultramarathon race.

Who is the study for?
This trial is for adult ultramarathon athletes who are in good health and ready to run an ultramarathon. They must be able to take pills, follow the study plan, and use effective birth control if they can have children. People under 18, pregnant or breastfeeding women, or those allergic to riboflavin cannot join.Check my eligibility
What is being tested?
The study tests whether taking riboflavin (vitamin B2) can prevent muscle soreness after running an ultramarathon compared to a placebo. Participants will be randomly assigned either riboflavin or a fake pill without knowing which one they're getting.See study design
What are the potential side effects?
Riboflavin is generally considered safe with minimal side effects; however, some may experience mild digestive upset or urine discoloration when taken at high doses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle soreness measure for long stage of the ultramarathon
Secondary outcome measures
Muscle soreness measure post-race

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Riboflavin GroupActive Control1 Intervention
Riboflavin 100mg will be self administered by participants, one capsules prior to the long stage of the race followed by a second dose at the completion of the long stage.
Group II: Placebo/Control GroupPlacebo Group1 Intervention
Placebo will be self administered by participants, one capsule prior to the long stage of the race followed by a second dose at the completion of the long stage.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
453 Previous Clinical Trials
91,030 Total Patients Enrolled
Steven MooreLead Sponsor
Racing the PlanetUNKNOWN

Media Library

Riboflavin (Vitamin) Clinical Trial Eligibility Overview. Trial Name: NCT05907850 — Phase < 1
Muscle Pain Research Study Groups: Placebo/Control Group, Riboflavin Group
Muscle Pain Clinical Trial 2023: Riboflavin Highlights & Side Effects. Trial Name: NCT05907850 — Phase < 1
Riboflavin (Vitamin) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05907850 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for volunteers in this clinical experiment?

"The information posted to clinicaltrials.gov validates that this trial, which was first listed on June 1st 2023 and last revised on June 8th 2023 is not currently recruiting patients. However, there are 27 alternative medical studies actively searching for participants at the moment."

Answered by AI
~165 spots leftby Dec 2024